In January, we added 121 citations in DIDB, including 58 in vitro (with 26 articles published in January 2023) and 63 in vivo articles (with 33 articles published in January 2023).
Two recently approved NDAs and BLAs were also added: adagrasib (KRIAZATI), teplizumab (TZIELD)
You can check the citations that are recently published and entered in DIDB and all the NDAs/BLAs in DIDB.
As always, feel free to contact us if you have any questions or comments.